Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.

M.G.E.H. Lam; A. Dahmane; W.H.M. Stevens; P.P. van Rijk; J.M.H. de Klerk; B.A. Zonnenberg

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.

Translated title of the contribution: Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.

M.G.E.H. Lam, A. Dahmane, W.H.M. Stevens, P.P. van Rijk, J.M.H. de Klerk, B.A. Zonnenberg

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
Original language	Undefined/Unknown
Pages (from-to)	756-765
Number of pages	10
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	35
Issue number	7
Publication status	Published - 2008

Cite this

@article{0d6679325d894b0398d750b14687e896,

title = "Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.",

author = "M.G.E.H. Lam and A. Dahmane and W.H.M. Stevens and {van Rijk}, P.P. and {de Klerk}, J.M.H. and B.A. Zonnenberg",

year = "2008",

language = "Undefined/Unknown",

volume = "35",

pages = "756--765",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer-Verlag",

number = "7",

}

TY - JOUR

T1 - Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.

AU - Lam, M.G.E.H.

AU - Dahmane, A.

AU - Stevens, W.H.M.

AU - van Rijk, P.P.

AU - de Klerk, J.M.H.

AU - Zonnenberg, B.A.

PY - 2008

Y1 - 2008

M3 - Article

SN - 1619-7070

VL - 35

SP - 756

EP - 765

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 7

ER -